Le rapport
Analyses approfondies du financement des entreprises, des stratégies de croissance et des insights de marché des entreprises les plus innovantes du monde
209 rapports et plus encore
Seaport Therapeutics Raises $225M in Series B
Seaport Therapeutics, a HealthTech company based in Boston, MA, has raised $225M in Series B from multiple investors.
Seaport Therapeutics raises $225M Series B
Seaport Therapeutics raises $225M in Series B. Biotech developing neuropsychiatric therapies...
Seaport Therapeutics raises $225M Series C at $1.2B valuation
Seaport Therapeutics raises $225M in Series C at $1.2B valuation. Neuropsychiatric disease treatments...
Seaport Therapeutics Raises $225 Million in Series B - October 21, 2024
Seaport Therapeutics announced $225 Million in Series B funding at a Undisclosed valuation. Seaport Therapeutics is a clinical-stage biopharmaceutical company developing novel therapies for neuropsychiatric disorders using prodrug technology ...
Arnatar Therapeutics raises $52M Series A
Arnatar Therapeutics raises $52M in Series A. Developing therapeutics for autoimmune and inflammatory diseases...
Denali Therapeutics raises $217M Series C at $5B valuation
Denali Therapeutics raises $217M in Series C at $5B valuation. Neurodegeneration therapeutics...
Strand Therapeutics raises $153M Series B
Strand Therapeutics raises $153M in Series B. mRNA-based therapeutics developer with novel cancer treatment platform...
Seres Therapeutics raises $113M Series E at $450M valuation
Seres Therapeutics raises $113M in Series E at $450M valuation. Microbiome therapeutic platform...
Crystalys Therapeutics raises $205M Series B at $900M valuation
Crystalys Therapeutics raises $205M in Series B at $900M valuation. Developing novel therapeutics for neurodegenerative diseases...
Affichage de 9 rapports • Page 1 • Catégorie : all
Restez en avance sur le marché
Recevez des insights hebdomadaires dans votre boîte de réception. Pas de spam, juste de l'intelligence.